Homozygous normoblastosis (nb/nb) mice, whose red blood cell (RBC) membranes are nearly completely deficient in fulllength 210-kD ankyrin, were used to study interactions between ankyrin and protein 4.2 (P4.2). Although it is unclear whether or not these proteins interact in the membrane, both ankyrin and P4.2 bind to the cytoplasmic domain of band 3 (cdb3). In addition to the complete deficiency of fulllength ankyrin, nb/nb RBC membranes are also partially spectrin deficient, resulting in morphologically spherocytic and mechanically fragile cells. We reported previously that RBCs from a patient with hereditary hemolytic anemia that were greater than 90% deficient of P4.2 had a concomitant decrease in the ability of ankyrin to remain stably associated with membranes after removal of spectrin and actin.5 Reconstitution of these membranes with P4.2 partially restored ankyrin binding, suggesting that binding of P4.2 to the cdb3 increased the stability of ankyrin-band 3 association^.^ In contrast, Korsgren and Cohen4 found evidence for in vitro interactions between purified P 4 2 and ankyrin, but not for interactions between these proteins in the membrane.
4.2 IS A 72-kD peripheral membrane protein that comprises -5% of the total red blood cell (RBC) membrane protein. Despite its relative abundance, little is known about its function in RBCs or in nonerythroid cells where it has been immunolocalized in both organelle and plasma membranes.' P4.2 is tightly associated with the membrane as evidenced by the harsh conditions, such as detergents, high pH, or strong chaotropic agents, that are required to extract it.' Even under these conditions, some P4.2 forms stable associations with other membrane proteins, in particular, ankyrin and band 3,334 suggesting that these proteins may interact in vivo. The major membrane binding site for P4.2 is the cytoplasmic domain of the transmembrane anion transporter protein band 3 (~d b 3 ) ,~ although interactions between P4.2 and other membrane proteins have also been r e p~r t e d . ~ We reported previously that RBCs from a patient with hereditary hemolytic anemia that were greater than 90% deficient of P4.2 had a concomitant decrease in the ability of ankyrin to remain stably associated with membranes after removal of spectrin and actin.5 Reconstitution of these membranes with P4.2 partially restored ankyrin binding, suggesting that binding of P4.2 to the cdb3 increased the stability of ankyrin-band 3 association^.^ In contrast, Korsgren and Cohen4 found evidence for in vitro interactions between purified P 4 2 and ankyrin, but not for interactions between these proteins in the membrane.
To clarify this issue, we examined P4.2-ankyrin interactions in normoblastosis mouse (nbhb) RBC membranes. Homozygous nbhb mice have severe hemolytic anemia with fragile short-lived RBCS.~ nb/nb RBCs are nearly completely deficient in full-length 210-kD ankyrin because of a defect in the Ank-l gene on mouse chromosome 8.' Instead, nb/nb RBC membranes contain small amounts of a truncated 150-kD form of ankyrin.' The near complete absence of 210-kD ankyrin in nbhb RBCs gave us the opportunity to test whether ankyrin deficiency would affect normal membrane associations of P4.2.
P MATERIALS AND METHODS

Animals.
Wild type (+I+) and homozygous normoblastosis (nb/ nb) mice were obtained as a gift from Dr Jane Barker (The Jackson Laboratory, Bar Harbor, ME is associated with a defect in the Ank-I gene on the centromeric end of chromosome 8.' ,&thalassemic mice and acetylphenylhydrazinetreated mice were gifts from Dr Mary Fabry (Albert Einstein College of Medicine, Bronx, NY).
P reparation of RBC ghosts and membrane vesicles. RBC ghosts were prepared from freshly drawn (intraorbital sinus) blood anticoagulated in heparin by the hypotonic lysis procedure of Dodge et a19 except that 0.4 mmoVL diisopropyl fluorophosphate was added at the lysis step. Spectrin-and actin-depleted inside-out vesicles (IOVs) were prepared by the method of Bennett and Branton,'" with some modifications; ghost membranes were incubated in 0.1 mmoU L Tris/HCI, pH 8 .0, at 37°C for 30 minutes to induce membrane vesiculation.
Preparation of antiserum. Polyclonal rabbit antibodies against human RBC ankyrin, protein 4.1, and P4.2 were prepared as described previo~sly.~ The antibodies were affinity purified using Affigel 10 (Bio-Rad Laboratories, Richmond, CA) coupled to the appropriate purified protein, according to the manufacturers' instructions. Polyclonal rabbit antihuman RBC ankyrin-(Ank-l) antibodies were a gift from the laboratory of Dr S.E. Lux (Boston, MA).
Gel electrophoresis and immunobbtting. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed using the discontinuous buffer system of Laemmli," or when ankyrin was to be quantitated, the continuous buffer system of Fairbanks et al. ' ratories, Richmond, CA). according to the manufacturers' instmctions.
Krricrrloc~re nrercrbolic labclirlg. Intraorbital blood from n t h t J
and P-thalassemic mice was collected. the RBCs pelleted by centrifugation and the huffy coat carefully removed by aspiration. RBCs were washed twice in 330 mOsm saline and separated from white blood cells (WBCs) using Ficoll-Paque (Pharmacia. Piscataway. NJ). WBC-free RBC pellets were collected by centrifugation and washed in 330 mOsm saline. Absence of WBCs was confirmed in stained smears. Reticulocyte counts were performed using an automated reticulocyte counter (Sysmex Model R-1000; Toa. Kobe, Japan) and veritied by manual determinations of new methylene blue-stained blood films. Equivalent amounts of reticulocytes ( I X 10') were taken for metabolic labeling. RBCs were washed once in RPMI-1640 cell culture media (GIBCO-BRL. Gaithersburg. MD) and resuspended in S mL of RPMI-I640 containing I O % fetal calf serum. The mixture was incubated at 37°C for IS minutes followed by addition of S00 pCi "S-methionine (NEG-009A; New England Nuclear. Boston, MA). Labeling proceeded for h0 minutes and aliquots were taken at timed intervals. Labeling was halted by washing the RBCs in ice-cold 330 mOsm saline and collecting the RBCs by centrifugation. After 4 more washings, the RBC pellets were resuspended in 0.5 mL 330 mOsm saline containing 0.025% saponin. supernatant-PBS mixture with 20 pL of affinity-purified polyclonal antihuman RBC P4.2 IgG in a 0.4 mL reaction volume containing 0.03% SDS and 0.44 mmol/L PMSF for 18 hours at 4"C, followed by addition of 50 p L of 10% (wt/vol) formalin-fixed Staphylococclts nurrrrs cells (SACs; Sigma Chemical CO, St Louis, MO) for 30 minutes at 4°C." SACs were collected in a microfuge and washed three times with PBS containing 0.05% NP-40 (Pierce Laboratories, Rockford. IL). Washed SAC pellet was resuspended in SO p1 of 2% SDS, I% 0-mercaptoethanol, vortexed to resuspend the pellet, boiled for S minutes and microfuged to pellet the SAC. Twenty-five-microliter aliquots of the supernatant were counted for radioactivity in S mL aqueous compatible liquid scintillation cocktail.
Purification and radiolabeling of o n k y i n and P4.2. Ankyrin and P4.2 were purified from human RBCs, according to the method of Bennett and Stenbuck" for ankyrin and the method of Korsgren and Cohen' for P4.2. For the P4.2 membrane-binding studies, the purified protein was radioiodinated using Bolton Hunter reagent (New England Nuclear, Boston, MA)."' Prrparation of ankvrin-reconstituted nblnb I0V.s. IOV membranes were prepared from nbhb mouse ghost membranes. as described above. The membranes were reconstituted with human RBC ankyrin (666 pg ankyridmg IOV). as described.'' Ankyrin reconstitution resulted in the repletion of =80% of +l+ IOV ankyrin levels determined by SDS-PAGE and densitometry. The content of band 3 in nbhb IOVs before and after ankyrin-reconstitution was within 8% of each other.
P4.2 binding to nblnb IOVs.
Binding of "'LP4.2 to nb/nb lOVs (with or without ankyrin reconstitution) was measured according to the method of Korsgren and Cohen,' with some modifications. Siliconized tubes were used and "I-P4.2 was precentrifuged at 40.000~ for 30 minutes at 4°C immediately before use. Under these conditions, nonspecific binding of "'I-P4.2 to IOVs was less than 20% as assayed with heat denatured "'I-P4.2. IOV protein was determined by the bicinchoninic acid method (Pierce Laboratories, Rockford, IL) after solubilizing in 1% SDS. "'I-P4.2 (0 to 150 pgl mL) was incubated with 20 pg nbhh lOVs in 120 mmollL KCI, S mmolL sodium phosphate, pH 8.0, 0.5 mmolL EGTA. 0.5 mmoll L DIT, 0.02% sodium azide (reassociation buffer) in a total volume of 0.25 mL for 18 hours at 4°C. For ankyrin-reconstituted nhhh IOVs. protein determinations were made after ankyrin reconstitution. lOVs were collected by centrifugation in a Beckman TLA 100.3 rotor at 50,000g for 30 minutes at 4°C in a Beckman Model TLA tabletop ultracentrifuge (Beckman Industries, Palo Alto, CA). lOVs were washed once in reassociation buffer and '*'I counted. Data were fitted using Enzfitter software version I .04 (Biosoft. Cambridge, UK) using a one-site ligand-binding equation.
RESULTS
nblnb RRC membrane protein analysis. As previously reported by Lux et al" and confirmed by Bodine et aLx n N nb RBC membranes are spectrin deficient (Fig IA) 
analysis showed a 40% spectrin deficiency that is comparable with the 50% deficiency previously reported." In contrast with human RBC membranes, mouse RBC membranes do not contain appreciable amounts of band 6 (glyceraldehyde-3-phosphate dehydrogenase), which may be due to the fact that the extreme N-terminal domain of band 3 that contains the band 6 binding site is poorly conserved in mouse band 3." A new finding was the nhhb membranes were severely P4.2 deficient along with the appearance of several lower molecular-weight bands migrating between P4.2 and actin (Fig 1A) . The P4.2 deficiency ranged from 42% (expressed as a ratio of P4.2 to band 3) to 73% (expressed as a ratio of P4.2 to protein 4.1) of wild-type +/+ mouse levels ( Table   l) . It is likely that the latter value is a more accurate representation of the actual P4.2 deficiency since loss of band 3 by membrane vesiculation that occurs in nbhb RBCs" would result in an underestimation of the P4.2 deficiency, P4.2 content of high reticulocyte mouse controls was normal when expressed as a ratio to band 3 (Table 1) .
Because nbhb mice are anemic and have 035% reticulocytes (earlier studies reported ~6 0 % reticulocytes for young adult nbhb mice'), it was possible that the P4.2 deficiency was an artifact of anemia and reticulocytosis. To assess this, we measured RBC membrane protein content in other anemic high reticulocyte mouse controls, including 0-thalassemic mice (27% reticulocytes) and acetylphenylhydrazinetreated mice (>50% reticulocytes). As shown in Fig IS, only the nbhb RBCs are P4.2 deficient, although several of the new protein bands migrating below P4.2 in nbhb RBCs are also found in the anemic controls, suggesting that some of these additional bands may be derived from proteolysis associated with high reticulocytosis. Immunologic analysis using polyclonal antihuman RBC P4.2 IgG confirmed the P4.2 deficiency in nb/nb RBC membranes (Fig IC) and also showed that the P4.2 deficiency was not a result of accelerated P4.2 degradation in vitro during membrane isolation because lower molecular-weight P4.2 bands were not detected in either nbhb or any of the other high reticulocyte mouse controls.
Western blot analysis using antihuman RBC ankyrin antibodies (anti-Ank-l) confirmed the absence of 210-kD full- and acetylphenylhydrazine-treated (>50% reticulocytes) mice. nbhb mice had 35% reticulocytes. RBC ghost membranes were prepared by hypotonic hemolysis? Membrane proteins were separated by SDS-PAGE on 9% acrylamide gels using the Laemmli discontinuous buffer system" and stained with Coomassie brilliant blue followed by laser densitometry to quantitate the amount of protein in the stained bands.
Results are the mean i 1 SD of the number of experiments shown in the parentheses. The probability of the null hypothesis was calculated using the Student's f-test (two-tailed. parametric distribution).
length ankyrin in nbhb RBC membranes, which was unique to nb/nh RBCs, not associated with anemia or high reticulocytosis, and confirmed the presence of small amounts of a truncated fotm of ankyrin in these membranes (Fig 1 D) .
To further rule out reticulocytosis as a cause of nhhb P4.2 deficiency, reticulocytosis was induced in +/+ mice by repeated phlebotomies. The presence of -20% reticulocytes had no effect on the amount of, or degradation of membrane P 4 2 (data not shown). Moreover, there was a marked decrease in the P4.2 content of nbhb compared with +l+ RBCs, that was not accompanied by P4.2 degradation (Fig IE) . Taken together, these results strongly suggest that the severe P4.2 deficiency of nbhb RBC membranes is unrelated to anemia or reticulocytosis and is not generated as an artifact during RBC membrane preparation and SDS-PAGE analysis.
Synthesis of P4.2 in nblnb reticulocytes. P4.2 synthesis was actively ongoing in nb/nb reticulocytes, and was even more active than in reticulocytes from anemic @-thalassemic mice (Fig 2) . Morphologic analysis of nb/nh and P-thalassemic reticulocytes showed that both contained early-stage stress reticulocytes, suggesting that reticulocyte age was similar (not shown). To exclude the possibility that P4.2 immunoprecipitation is sensitive to different levels of P4.2 present in the nbhb and @-thalassemic reticulocytes, we performed an immunologic titration of radiolabeled P4.2 over a 400-fold concentration range. Recovery of protein over this range was 88% ? 2%, indicating that the different levels of P4.2 present in the mouse reticulocytes were not contributing to artifactual differences in the measured synthetic rates (not shown).
Binding of P4.2 to ankyrin-reconstituted nblnb rnernbranes. Reconstitution of nbhb IOVs with human RBC
ankyrin resulted in the restoration of 080% of +/+ IOV ankyrin levels (Fig 3A) . Ankyrin-reconstituted nbhh IOVs had increased binding of "'I-P4.2 compared with ankyrindeficient nbhb IOVs (Fig 3B) . Because IOV protein quantitation was assayed after ankyrin reconstitution, the actual amount of P4.2-binding augmentation by ankyrin (expressed per milligram IOV) is likely to be higher than represented. For these experiments, radiolabeled P4.2 was purified from human RBCs by the original method of Korsgren and Cohen using potassium iodide as the chaotropic salt during gel filtration.3 Radiolabeled P4.2 prepared by the alternative procedure of Korsgren and Cohen' did not give reproducible binding in our assays.
DISCUSSION
Mice homozygous for the normobiastosis (nb/nb) mutdtion have RBCs almost completely deficient in full-length 210-kD ankyrin and instead have a small amount of a truncated ankyrin species.' The ankyrin deficiency results in a secondary spectrin deficiency and fragile spherocytic RBCs subject to shortened survival." We find that the nbhb RBC membranes are also ~7 3 % deficient in P4.2 as determined by SDS-PAGE analysis and verified by Western blotting using polyclonal antihuman RBC P4.2 antibodies. Control studies showed that the P4.2 deficiency was not caused by anemia, reticulocytosis, or in vitro protein degradation during membrane preparation and SDS-PAGE analysis.
For Labeling Time (mins) Fig 2. Mouse reticulocyte P4.2 synthesis. Reticulocytes were isolated from nb/nb (U) or P-thalassemic ( 0 ) mice and equivalent amounts were metabolically labeled with "S-methionine. P4.2 was immunoprecipitated from RBC lysates using affinity-purified anti-P4.2 IgG and formalin-fixed SACS. Results given as the incorporation of "S-methionine (counts per minute) into P4.2 per 1 x 10' reticulocytes.
The presence of ~2 5 % of P4.2 in n l h h membranes despite near complete absence of 210-kD ankyrin suggests several possibilities: ( l ) the absence of 210-kD ankyrin reduces high-affinity P4.2 binding to cdb3. but allows partial low-affinity binding; (2) the 150-kD truncated ankyrin is capable of providing partial enhancement of P4.2 binding to cdb3: (3) P4.2 binds to membrane sites other than cdb3. This possibility is consistent with earlier in vitro findings of Korsgren and Cohen' who reported that proteolytic elimination of most of the high-affinity band 3 binding sites in P4.2-stripped IOVs decreased, but did not eliminate P4.2 membrane binding.
Metabolic labeling studies showed that nbhb reticulocytes were actively synthesizing P4.2 at rates comparable with pthalassemic high-reticulocyte mouse controls. Morphologic analysis of r t l h l ? and &thalassemic reticulocytes showed that both populations contained young stress reticulocytes, making it less likely that differences in reticulocyte rnatura- Our findings differ from earlier results of Korsgren and Cohen4 who found no evidence for ankyrin enhancement of P4.2 binding to ankyrin-reconstituted stripped IOVs. Possible reasons for this difference could be that (1) pH 1 1 extraction used to strip IOVs altered or denatured cdb3 in a way that prevented ankyrin enhancement of P4.2 binding; (2) different levels of P4.2 and ankyrin were used in the binding experiments; or (3) as stated above, species differences were a factor (human v mouse IOVs).
In human RBC membranes, band 3 exists as dimers, tetramers, and higher order oligomers,22 the latter forms are thought to be stabilized by direct interactions with cytoskeletal proteins.22 Because ankyrin and P4.2 bind to distinct sites on ~db3,4.'~.'' mechanisms by which ankyrin could enhance the binding of P4.2 to cdb3 include (1) ankyrin-induced stabilization of specific conformational or self-association states of band 3; (2) ankyrin deficiency could result in modification of the cdb3 binding site for P4.2, resulting in poorly bound protein that is susceptible to endogenous proteolysis. We did not find evidence of P4.2 proteolysis in nb/nb ankyrin-deficient membranes, suggesting that proteolysis occurs before the release of circulating RBCs or that the P4.2 degradation products are very small and avoid detection in our system. An alternative explanation for the deficiency of P4.2 in the ankyrin-deficient nbhb RBCs is a second genetic mutation that affects P4.2 synthesis. This is unlikely because metabolically labeled nbhb reticulocytes actively synthesize P4.2. Moreover, the mouse ankyrin gene is (Ank-l) located on chromosome 8,' whereas the mouse P4.2 gene is located on chromosome 2,?' precluding any linkage between these genetic defects.
If ankyrin is required for normal associations of P4.2 with band 3, then why is it that ankyrin can be extracted from RBC membranes under conditions that have little effect on the removal of P4.224? One explanation could be that binding of ankyrin to band 3 promotes high-affinity P4.2 binding to some other membrane site and once P4.2 is bound, subsequent removal of ankyrin would not result in P4.2 release. This would imply that band 3 molecular interactions are important in establishing normal P4.2 binding. Alternatively, it is possible that binding of P4.2 to band 3 establishes interactions between P4.2 and other membrane components that stabilize its membrane binding in the absence of ankyrin.
We conclude from these studies that ankyrin enhances the association of P4.2 with RBC membranes. This conclusion is consistent with naturally occurring human RBC ankyrin deficiency that is associated with a secondary partial P4.2
That the P4.2 deficiency associated with ankyrin deficiency is not secondarily caused by spectrin deficiency is likely because RBC P4.2 content is normal in hereditary spherocytosis
RBCs with a primary spectrin deficiency in the absence of ankyrin deficiency in both humans" and mice.'
